EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Link REIT (823 HK)

Real Estate

Aequitas Research

Shocks the market with a US$2.4bn rights issue (30% discount to the undisturbed price of HK$62.80 as of 9th Feb & 45% discount to NAV Sep 22) and comes shortly after the group announced a S$2.2bn acquisition of two Singapore assets in late Dec 2022, where management explicitly mentioned that they didn’t need to raise any new capital. The issue is complicated even further by the fact that management has spent HK$400m+ over the past year buying back its units at prices above where the stock is trading now. In this note, Sumeet Singh talks about the rights issue, its previous acquisition and the overall implications.

Edition: 154

- 17 February, 2023